Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 748-751

  Venkateswarlu, K ^a   Taylor, M ^a   Manning, N J ^b   Rinaldi, M G ^c   Kelly, S L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DRUG TOLERANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030899227     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.748     Document Type: Article

References (24)

1. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, W. J. Martone, and the National Nosocomial Infections Surveillance System. 1991. Secular trends in nosocomial primary bloodstream infections in the United States. Am. J. Med. 91(Suppl. 3B):86S-89S.
2. Beck-Sague, C. M., and W. R. Jarvis. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
3. Bodey, G. P., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martino, E. Meunier, S. Milliken, S. Naoe, M. Okudaira, D. Scevola, and J. van't Wout. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
4. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
5. Joseph-Horne, T., D. Hollomon, N. Manning, and S. L. Kelly. 1995. Investigation of the sterol composition and azole resistance in field isolates of Septoria tritici. Appl. Environ. Microbiol. 62:184-190.
6. Joseph-Horne, T., D. Hollomon, R. S. T. Loeffler, and S. L. Kelly. 1995. Altered P450 activity associated with direct selection for fungal azole resistance. FEBS Lett. 374:174-178.
7. Joseph-Horne, T., D. Hollomon, R. S. Thomas Loeffler, and S. L. Kelly. 1995. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob. Agents Chemother. 39:1526-1529.
8. Kelly, S. L., A. Arnoldi, and D. E. Kelly. 1993. Molecular-genetic analysis of azole antifungal mode of action. Biochem. Soc. Trans. 21:1034-1038.
9. Kelly, S. L., and D. E. Kelly. 1993. Molecular studies on azole sensitivity in fungi, p. 199-213. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and applications to medical mycology. Springer-Verlag, Berlin, Germany.
10. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14α-methyl-ergosta-8,24(28)-dien-3ß,6α-diol. Biochem. Biophys. Res. Commun. 207:910-915.
11. 8→7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122:39-42.
12. Lamb, D. C., A. Corran, B. C. Baldwin, J. Kwon-Chung, and S. L. Kelly. 1995. Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients. FEBS Lett. 368:326-330.
13. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
14. Quail, M. A., A. Arnoldi, D. J. Moore, M. W. Goosey, and S. L. Kelly. 1993. Ketoconazole mediated growth inhibition in Botrytis cinerea and Saccharomyces cerevisiae. Phytochemistry 32:273-280.
15. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
16. Scholer, H. J., and A. Polak. 1984. Resistance to systemic antifungal agents. p. 393-483. In L. E. Bryan (ed.). Antimicrobial drug resistance. Academic Press, Inc., New York, N.Y.
17. Thomas Loeffler, R. S., and A. L. Hayes. 1992. Effects of sterol biosynthesis inhibitor fungicides on growth inhibition in Ustilago maydis, Botrytis cinera and Pyrenophora teres. Pestic. Sci. 35:7-17.
18. Vanden Bossche, H., P. Marichal, J. Gorrens, and M. C. Coene. 1990. Biochemical basis for the activity and selectivity of oral antifungal drugs. Br. J. Clin. Pract. Symp. 44(Suppl. 71):41-46.
19. Vanden Bossche, H., P. Marichal, J. Gorrens, M. C. Coene, G. Willemsens, D. Bellens, I. Roels, H. Moereels, and P. A. Janssen. 1989. Biochemical approaches to selective antifungal activity: focus on azole antifungals. Mycoses 32:35-52.
20. Vanden Bossche, H., P. Marichal, L. Le Jeune, M.-C. Coene, J. Gorrens, and W. Cools. 1993. Effects of itraconazole on cytochrome P-450-dependent sterol 14α-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob. Agents Chemother. 37:2101-2105.
21. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microhiol. Lett. 131:337-341.
22. Wang, Y., and A. Casadevall. 1994. Growth of Cryptococus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicroh. Agents Chemother. 38:2648-2650.
23. Watson, P. F., M. E. Rose, S. W. Ellis, H. England, and S. L. Kelly. 1989. Defective sterol C5,6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem. Biophys. Res. Commun. 164:1170-1175.
24. Woods, R. A. 1971. Nystatin-resistant mutants of yeast: alteration in sterol content. J. Bacteriol. 108:69-73.